UK markets open in 2 hours 50 minutes

Cumberland Pharmaceuticals Inc. (CPIX)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
1.7000+0.0900 (+5.59%)
At close: 04:00PM EDT
1.6350 -0.07 (-3.82%)
After hours: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
39,553
39,553
42,011
35,985
37,441
Cost of revenue
6,067
6,067
9,119
8,811
8,653
Gross profit
33,486
33,486
32,892
27,174
28,788
Operating expenses
Research development
5,834
5,834
6,689
5,684
5,774
Selling general and administrative
29,104
29,104
26,841
24,795
24,962
Total operating expenses
43,041
43,041
38,597
34,851
35,170
Operating income or loss
-9,555
-9,555
-5,705
-7,677
-6,382
Interest expense
667.861
667.861
585.995
98.031
263.627
Total other income/expenses net
3,651
3,651
611.33
2,187
-
Income before tax
-6,285
-6,285
-5,581
-5,562
-6,570
Income tax expense
45.769
45.769
68.85
34.891
55.902
Income from continuing operations
-6,331
-6,331
-5,650
-5,597
-6,626
Net income
-6,279
-6,279
-5,570
-3,508
-3,339
Net income available to common shareholders
-6,279
-6,279
-5,570
-3,508
-3,339
Basic EPS
-0.17
-0.44
-0.38
-0.24
-0.22
Diluted EPS
-0.17
-0.44
-0.38
-0.24
-0.22
Basic average shares
14,357
14,299
14,564
14,905
15,162
Diluted average shares
14,491
14,299
14,564
14,905
15,162